Novacyt

The Novacyt Group is a rapidly growing, international diagnostics business generating an increasing portfolio of in vitro and molecular diagnostic tests. Its core strengths lie in diagnostics product development, commercialisation, contract design and manufacturing. The Company’s lead business units comprise of Primerdesign and Lab21 Products, supplying an extensive range of high quality assays and reagents worldwide. The Group directly serves oncology, microbiology, haematology and serology markets as do its global partners, which include major corporates.

Steve Gibson

CFO and Board Member

Graham Mullis

CEO

Ruth Powell

Managing Director of NOVAprep and Lab21 Services

Ian Wilde

RA and QA Director

4 past transactions

IT-IS International

Acquisition in 2020
IT-IS is a UK based diagnostic instrument development and manufacturing company specializing in the development of PCR devices for the life sciences and food testing industry.

Primer Design

Acquisition in 2016
Primerdesign Ltd specialises in real-time PCR.

Lab21

Acquisition in 2014
Lab21 is a rapidly growing healthcare diagnostics business. The company’s vision is of providing personalised diagnostic testing for disease identification, disease predisposition and personalised medicine to protect people from the health problems of tomorrow. We believe that ‘prevention is better than cure’ and aim to provide information that helps to protect people from their health problems of tomorrow.Lab 21 Clinical Laboratory supports healthcare providers and the pharmaceutical and biotechnology industries with technically advanced testing services from its accredited facilities in Cambridge, UK. The Lab 21 team’s experience and know-how is coupled with a rapidly growing portfolio of molecular and viral diagnostics, plus next generation sequencing, pharmacogenetic and patient profiling tests, which all use cutting-edge technology. This unique combination adds value to pharmaceutical, diagnostic and biotech partners – and directly to clinicians or healthcare providers as they treat and monitor their patients.As we move towards truly personalised healthcare, the Lab 21 team contributes today – delivering high-quality information on drugs and patients that provides real clinical insight.

Centre de Compétences International en Tele-Imagerie

Acquisition in 2013
Centre de Compétences International en Tele-Imagerie designs and develops software suite for digital pathology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.